Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhib... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma
0
Authors
Toni Choueiri
22 more
Toni Choueiri
•
Ulka Vaishampayan
20 more
•
Ramaprasad Srinivasan
Published
December 4, 2012
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Clinical Oncology
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1200/jco.2012.43.3383
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Clinical Oncology
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1200/jco.2012.43.3383
Other Formats
PDF
